【结 构 式】 |
【药物名称】Eformoterol fumarate, Formoterol fumarate, CGP-25827A(free base), YM-08316, BD-40A(anhydrous), Foradil Aerolizer, Foradil Certihaler, Broncoral, Oxeze Turbuhaler, Oxis Turbuhaler, Foradil, Atock 【化学名称】(±)-N-[2-Hydroxy-5-[1(R*)-hydroxy-2-[1(R*)-methyl-2-(4-methoxyphenyl)ethylamino]ethyl]phenyl]formamide fumarate (2:1) monohydrate 【CA登记号】43229-80-7 (anhydrous), 73573-87-2 (anhydrous; free base) 【 分 子 式 】C42H54N4O13 【 分 子 量 】822.91768 |
【开发单位】Yamanouchi (Originator), Schering-Plough (Marketer), AstraZeneca (Licensee), Ferrer (Licensee), Novartis (Licensee), Chiesi (Formulation), ML Laboratories (Formulation), Orion Corp. (Formulation), SkyePharma (Formulation) 【药理作用】Asthma Therapy, Bronchodilators, Chronic Obstructive Pulmonary Diseases (COPD), Treatment of, RESPIRATORY DRUGS, beta2-Adrenoceptor Agonists |
合成路线1
The bromination of 4 benzyloxy-3-nitroacetophenone (I) with Br2 in CHCl3 gives 4-benzyloxy-3-nitro-alpha-bromoacetophenone (II), which is then condensed with N-benzyl-N-(1-methyl-2-(p-methoxyphenyl)ethyl]-amine (III) in butanone at 80 C yielding 4-benzyloxy-3-nitro-alpha-[N-benzyl-N-[1-methyl-2-(p-methoxyphenyl)ethyl]amino]acetophenone (IV). The reduction of the carbonyl group of (IV) with NaBH4 in ethanol affords the corresponding nitro alcohol (V), which is reduced again with Fe and HCl in ethanol - water to the amino alcohol (VI). The formylation of (VI) with formic acid in acetic anhydride gives 4-benzyloxy-3-formyl-amino-alpha-[N-benzyl-N-[1-methyl-2-(p-methoxyphenyl)ethyl]aminomethyl]benzyl alcohol (VII), which is finally debenzylated with H2 over Pd/C in ethanol and treated with fumaric acid (A).
【1】 Murakami, M.; et al.; alpha-Aminomethylbenzylalkoholderivative. DE 2305092; DE 2366625 . |
【2】 Castaner, J.; Weetman, D.F.; BD 40A. Drugs Fut 1977, 2, 10, 639. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 23808 | Fumaric acid; (E)-2-butenedioic acid | 110-17-8 | C4H4O4 | 详情 | 详情 |
(I) | 20627 | 1-[4-(benzyloxy)-3-nitrophenyl]-1-ethanone | C15H13NO4 | 详情 | 详情 | |
(II) | 32763 | 1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanone | C15H12BrNO4 | 详情 | 详情 | |
(III) | 33904 | (2S)-N-benzyl-1-(4-methoxyphenyl)-2-propanamine; N-benzyl-N-[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amine | C17H21NO | 详情 | 详情 | |
(IV) | 33900 | 2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]-1-ethanone | C32H32N2O5 | 详情 | 详情 | |
(V) | 33901 | (1R)-2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]-1-ethanol | C32H34N2O5 | 详情 | 详情 | |
(VI) | 33902 | (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-ethanol | C32H36N2O3 | 详情 | 详情 | |
(VII) | 33903 | 5-((1R)-2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide | C33H36N2O4 | 详情 | 详情 |
合成路线2
By reduction of a mixture of 1-(3-formylamino-4-hydroxyphenyl)-2-aminoethanol (VIII) and 1-(4-methoxyphenyl)-2-propanone (IX) with H2 over Pt in ethanol, followed by a treatment with fumaric acid (A).
【1】 Tanoury GJ, Hett R,Kessler D,et aL 2002. Taking advantage of polymorphism to effect an impurity removalt: development of a thermodynamic crystal form of (R,R)-fonnoterol tartnte. Org Proc Res Dev,6 (6).855~862 |
【1】 Murase, K.; et al.; JP 7512040 . |
【2】 Castaner, J.; Weetman, D.F.; BD 40A. Drugs Fut 1977, 2, 10, 639. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 23808 | Fumaric acid; (E)-2-butenedioic acid | 110-17-8 | C4H4O4 | 详情 | 详情 |
(I) | 66381 | (1R,2S)-1-Amino-2-indanol | 7480-35-5 | C9H11NO | 详情 | 详情 |
(II) | 32764 | (3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole | C9H10BNO | 详情 | 详情 | |
(III) | 32765 | (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol | 188690-82-6 | C15H14BrNO4 | 详情 | 详情 |
(IV) | 32766 | (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-bromo-1-ethanol | C15H16BrNO2 | 详情 | 详情 | |
(V) | 32767 | 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide | C16H16BrNO3 | 详情 | 详情 | |
(VI) | 32738 | tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate | C34H48N2O6S2 | 详情 | 详情 | |
(VII) | 32769 | 5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide | C33H36N2O4 | 详情 | 详情 | |
(VIII) | 33905 | 5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenylformamide | C9H12N2O3 | 详情 | 详情 | |
(VIII) | 66382 | N-[2-Hydroxy-5-[1(R)-hydroxy-2-[2-(4-methoxyphenyl)-1(R)-methylethylamino]ethyl]phenyl]formamide | 67346-49-0 | C19H24N2O4 | 详情 | 详情 |
(IX) | 10038 | 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone | 122-84-9 | C10H12O2 | 详情 | 详情 |
合成路线3
【1】 Tanoury GJ, Hett R,Kessler D,et aL 2002. Taking advantage of polymorphism to effect an impurity removalt: development of a thermodynamic crystal form of (R,R)-fonnoterol tartnte. Org Proc Res Dev,6 (6).855~862 |
【1】 Murase, K.; et al.; JP 7512040 . |
【2】 Castaner, J.; Weetman, D.F.; BD 40A. Drugs Fut 1977, 2, 10, 639. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 23808 | Fumaric acid; (E)-2-butenedioic acid | 110-17-8 | C4H4O4 | 详情 | 详情 |
(I) | 66381 | (1R,2S)-1-Amino-2-indanol | 7480-35-5 | C9H11NO | 详情 | 详情 |
(II) | 32764 | (3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole | C9H10BNO | 详情 | 详情 | |
(III) | 32765 | (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol | 188690-82-6 | C15H14BrNO4 | 详情 | 详情 |
(IV) | 32766 | (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-bromo-1-ethanol | C15H16BrNO2 | 详情 | 详情 | |
(V) | 32767 | 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide | C16H16BrNO3 | 详情 | 详情 | |
(VI) | 32738 | tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate | C34H48N2O6S2 | 详情 | 详情 | |
(VII) | 32769 | 5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide | C33H36N2O4 | 详情 | 详情 | |
(VIII) | 33905 | 5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenylformamide | C9H12N2O3 | 详情 | 详情 | |
(VIII) | 66382 | N-[2-Hydroxy-5-[1(R)-hydroxy-2-[2-(4-methoxyphenyl)-1(R)-methylethylamino]ethyl]phenyl]formamide | 67346-49-0 | C19H24N2O4 | 详情 | 详情 |
(IX) | 10038 | 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone | 122-84-9 | C10H12O2 | 详情 | 详情 |
合成路线4
【1】 Tanoury GJ, Hett R,Kessler D,et aL 2002. Taking advantage of polymorphism to effect an impurity removalt: development of a thermodynamic crystal form of (R,R)-fonnoterol tartnte. Org Proc Res Dev,6 (6).855~862 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VI) | 32738 | tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate | C34H48N2O6S2 | 详情 | 详情 | |
(IX) | 10038 | 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone | 122-84-9 | C10H12O2 | 详情 | 详情 |
(X) | 32770 | N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine; N-benzyl-1-(4-methoxyphenyl)-2-propanamine | C17H21NO | 详情 | 详情 |
合成路线5
【1】 Zhao LQ,Zhao DM,Zhang YF.et al.2000.Synthesis of 2-adrenoceptor agonist formoterol.中国药物化学杂志,10 (4): 285 --287 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 32763 | 1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanone | C15H12BrNO4 | 详情 | 详情 | |
(II) | 50312 | (2R)-2-[4-(benzyloxy)-3-nitrophenyl]oxirane; benzyl 2-nitro-4-[(2R)oxiranyl]phenyl ether | C15H13NO4 | 详情 | 详情 | |
(III) | 66383 | 1-(4-Methoxyphenyl)propan-2-amine | 50505-80-1 | C10H15NO | 详情 | 详情 |
(IV) | 66384 | 1-(4-(benzyloxy)-3-nitrophenyl)-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethanol | C25H28N2O5 | 详情 | 详情 | |
(V) | 66385 | 1-(3-amino-4-(benzyloxy)phenyl)-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethanol hydrochloride | C25H30N2O3.HCl | 详情 | 详情 | |
(VI) | 66386 | N-(2-(benzyloxy)-5-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide hydrochloride | C26H31ClN2O4 | 详情 | 详情 | |
(VII) | 23808 | Fumaric acid; (E)-2-butenedioic acid | 110-17-8 | C4H4O4 | 详情 | 详情 |
合成路线6
【1】 Campos F.Bosch MP,Guerrero A. 2000.An efficient enantioselective synthesis of(R, R)-formoterol,a potent bronchodilator, using lipases. Tetrahedron: Asymm, 11 (13): 2705~2717 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 66388 | (R)-N-(1-(4-methoxyphenyl)propan-2-yl)prop-1-en-2-amine | C13H19NO | 详情 | 详情 | |
(II) | 66387 | (R)-1-(4-methoxyphenyl)propan-2-amine | 58993-79-6 | C12H17NO2 | 详情 | 详情 |
(III) | 66389 | 2-(benzyloxy)-5-(2-bromo-1-hydroxyethyl)benzoic acid | C16H15BrO4 | 详情 | 详情 | |
(IV) | 66390 | (R)-1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethyl acetate | C17H16BrNO5 | 详情 | 详情 | |
(V) | 32765 | (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol | 188690-82-6 | C15H14BrNO4 | 详情 | 详情 |
(VI) | 50312 | (2R)-2-[4-(benzyloxy)-3-nitrophenyl]oxirane; benzyl 2-nitro-4-[(2R)oxiranyl]phenyl ether | C15H13NO4 | 详情 | 详情 | |
(VII) | 66391 | (R)-1-(4-(benzyloxy)-3-nitrophenyl)-2-(((R)-1-(4-methoxyphenyl)propan-2-yl)amino)ethanol | C25H28N2O5 | 详情 | 详情 | |
(VIII) | 66392 | (R)-1-(3-amino-4-(benzyloxy)phenyl)-2-(((R)-1-(4-methoxyphenyl)propan-2-yl)amino)ethanol | C25H30N2O3 | 详情 | 详情 | |
(IX) | 66393 | N-(2-(benzyloxy)-5-((R)-1-hydroxy-2-(((R)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide | C26H30N2O4 | 详情 | 详情 | |
(X) | 66382 | N-[2-Hydroxy-5-[1(R)-hydroxy-2-[2-(4-methoxyphenyl)-1(R)-methylethylamino]ethyl]phenyl]formamide | 67346-49-0 | C19H24N2O4 | 详情 | 详情 |